Abstract:Dok1 and Dok2 proteins play a crucial role in myeloid cell proliferation as demonstrated by Dok1 and Dok2 gene inactivation, which induces a myeloproliferative disease in aging mice. In this study, we show that Dok1/Dok2 deficiency affects myeloproliferation even at a young age. An increase in the cellularity of multipotent progenitors is observed in young Dok1/Dok2-deficient mice. This is associated with an increase in the cells undergoing cell cycle, which is restricted to myeloid committed progenitors. Furt… Show more
“…The number of total mononuclear cells, Lin À Sca1 + c-Kit + cells, and Lin À Sca1 À c-Kit + myeloid progenitors (MPs) in the bone marrow of Spib À/À mice was comparable to WT mice ( Figures 3B and 3C). MPs are further divided into CMP, GMP, and MEP based on the expression of CD34 and FcgRII/III (Coppin et al, 2016). While these three progenitors were numerically similar in WT bone marrow, there were more GMP and fewer MEP in the Spib À/À mice ( Figures 3C and 3D).…”
Section: Spi-b Deficiency Results In Expansion Of Mast Cells Due To Amentioning
Mast cells are important for eradication of intestinal nematodes; however, their precise mechanisms of action have remained elusive, especially in the early phase of infection. We found that Spi-B-deficient mice had increased numbers of mast cells and rapidly expelled the Heligmosomoides polygyrus (Hp) nematode. This was accompanied by induction of interleukin-13 (IL-13)-producing group 2 innate lymphoid cells (ILC2) and goblet cell hyperplasia. Immediately after Hp infection, mast cells were rapidly activated to produce IL-33 in response to ATP released from apoptotic intestinal epithelial cells. In vivo inhibition of the P2X7 ATP receptor rendered the Spi-B-deficient mice susceptible to Hp, concomitant with elimination of mast cell activation and IL-13-producing ILC2 induction. These results uncover a previously unknown role for mast cells in innate immunity in that activation of mast cells by ATP orchestrates the development of a protective type 2 immune response, in part by producing IL-33, which contributes to ILC2 activation.
“…The number of total mononuclear cells, Lin À Sca1 + c-Kit + cells, and Lin À Sca1 À c-Kit + myeloid progenitors (MPs) in the bone marrow of Spib À/À mice was comparable to WT mice ( Figures 3B and 3C). MPs are further divided into CMP, GMP, and MEP based on the expression of CD34 and FcgRII/III (Coppin et al, 2016). While these three progenitors were numerically similar in WT bone marrow, there were more GMP and fewer MEP in the Spib À/À mice ( Figures 3C and 3D).…”
Section: Spi-b Deficiency Results In Expansion Of Mast Cells Due To Amentioning
Mast cells are important for eradication of intestinal nematodes; however, their precise mechanisms of action have remained elusive, especially in the early phase of infection. We found that Spi-B-deficient mice had increased numbers of mast cells and rapidly expelled the Heligmosomoides polygyrus (Hp) nematode. This was accompanied by induction of interleukin-13 (IL-13)-producing group 2 innate lymphoid cells (ILC2) and goblet cell hyperplasia. Immediately after Hp infection, mast cells were rapidly activated to produce IL-33 in response to ATP released from apoptotic intestinal epithelial cells. In vivo inhibition of the P2X7 ATP receptor rendered the Spi-B-deficient mice susceptible to Hp, concomitant with elimination of mast cell activation and IL-13-producing ILC2 induction. These results uncover a previously unknown role for mast cells in innate immunity in that activation of mast cells by ATP orchestrates the development of a protective type 2 immune response, in part by producing IL-33, which contributes to ILC2 activation.
“…Tumor suppressing roles of DOK1 / 2 have been reported in solid tissues and hematopoietic compartment in several studies (Berger et al, ; Coppin et al, ; Ghanem, Bracken, Kasem, Jiang, & Mokbel, ; Lee et al, , 2007; Niki et al, ; Yasuda et al, ). Genetic disruption of DOK1 / 2 in animal models and human tumor samples increased their susceptibility to leukemia development (Celis‐Gutierrez et al, ; Coppin et al, ; Mashima et al, , ; Niki et al, ; Yasuda et al, ). Niki et al () and Yasuda et al () through functional studies in vivo revealed that DOK1 / 2 inactivation resulted in hyperplasia of myeloid progenitors at various stages and markedly accelerated leukemia.…”
Section: Discussionmentioning
confidence: 99%
“…Downstream of tyrosine kinase ( DOK ), a large family of phosphotyrosine adapters, are substrates of protein tyrosine kinases (Coppin et al, ). Seven members ( DOK1 – DOK7 ) of DOK family have been identified, and these members were found to be implicated in the regulation of multiple biological processes, including cell growth, transformation, differentiation, motility, and death (Celis‐Gutierrez et al, ; Mashima, Hishida, Tezuka, & Yamanashi, , Mashima et al, ).…”
DOK-1 and DOK-2 (DOK1/2) are closely related members of downstream of tyrosine kinase (DOK) family genes, which are found to be frequently rearranged in several hematopoietic cancers. However, the clinical implications of DOK1/2 in acute myeloid leukemia (AML) remain largely unknown. To investigate the clinical significance, real-time quantitative PCR (RQ-PCR) was carried out to detect DOK1/2 expressions in 125 de novo AML patients and 28 healthy controls. Real-time quantitative methylation-specific PCR (RQ-MSP) and bisulfite sequencing PCR (BSP) were applied to detect DOK1/2 methylation level and density. DOK1/2 expressions were significantly down-regulated in AML patients. The promoters of DOK1/2 were highly hypermethylated and negatively correlated with DOK1/2 expressions in AML patients. In addition, we also confirmed that DOK1/2 expressions could be restored by DOK1/2 demethylation using 5-aza-2'-deoxycytidine in leukemia cell line THP-1. Survival analyses showed that low-expressed DOK1/2 were associated with markedly shorter overall survival and leukemia free survival in both whole-cohort AML and non-M3 AML patients. Multivariate analyses further revealed that DOK1/2 were act as independent prognostic factors in AML patients. These findings indicate that decreased DOK1/2 expressions associated with their promoter hypermethylations predict adverse prognosis in AML.
“…These two closely related Dok family members are involved in the regulation of several cellular processes, such as proliferation, differentiation, and migration. Using Dok-1-and -2 (Dok-1/2)-deficient mice, biological roles for Dok-1 and Dok-2 have been demonstrated in antibody responses to thymus-dependent antigens, NK and hematopoietic cell development and function, innate immune response to lipopolysaccharide (LPS), myeloid homeostasis, and leukemia suppression (29)(30)(31)(32)(33)(34)(35)(36). In addition, we recently demonstrated that Dok proteins regulate the CD8 ϩ T cell response to an exogenous epitope expressed by vaccinia virus (VV) (37).…”
Dok-1 and Dok-2 negatively regulate responses downstream of several immune receptors in lymphoid and myeloid cells. Recent evidence showed that Dok proteins are essential in the formation of memory CD8 ϩ T cells to an exogenous epitope expressed by vaccinia virus; however, the importance of Dok-1 and Dok-2 in the control of viral infection is unknown. Here, we investigated the role of Dok proteins in modulating the immune response against herpes simplex virus 1 (HSV-1) in a mouse model of ocular infection. During acute infection, viral titers in the eye were similar in wild-type (WT) and Dok-1 and Dok-2 double-knockout (DKO) mice, and the percentages of infiltrating leukocytes were similar in DKO and WT corneas and trigeminal ganglia (TG). DKO mice exhibited a diminished CD8 ϩ T cell response to the immunodominant HSV-1 glycoprotein B (gB) epitope in the spleen and draining lymph nodes compared to WT mice during acute infection. Remarkably, gB-specific CD8 ϩ T cells almost completely disappeared in the spleens of DKO mice during latency, and the reduction of CD8 ϩ effector memory T (Tem) cells was more severe than that of CD8 ϩ central memory T (Tcm) cells. The percentage of gB-specific CD8 ϩ T cells in TG during latency was also dramatically reduced in DKO mice; however, they were phenotypically similar to those from WT mice. In ex vivo assays, reactivation was detected earlier in TG cultures from infected DKO versus WT mice. Thus, Dok-1 and Dok-2 promote survival of gB-specific CD8 ϩ T cells in TG latently infected with HSV-1.IMPORTANCE HSV-1 establishes lifelong latency in sensory neurons of trigeminal ganglia (TG). In humans, HSV-1 is able to sporadically reactivate from latently infected neurons and establish a lytic infection at a site to which the neurons project. Most herpetic disease in humans is due to reactivation of HSV-1 from latency rather than to primary acute infection. CD8 ϩ T cells are thought to play an important role in controlling recurrent infections. In this study, we examined the involvement of Dok-1 and Dok-2 signaling proteins in the control of HSV-1 infection. We provide evidence that Dok proteins are required to maintain a CD8 ϩ T cell response against HSV-1 during latency-especially CD8 ϩ Tem cells-and that they negatively affect HSV-1 reactivation from latency. Elucidating Dok-mediated mechanisms involved in the control of HSV-1 reactivation from latency might contribute to the development of therapeutic strategies to prevent recurrent HSV-1-induced pathology.KEYWORDS CD8 ϩ T cell, T cell immunity, Dok proteins, herpes simplex virus, herpesviruses, viral pathogenesis F ollowing experimental corneal infection of C57BL/6 (B6) mice, herpes simplex virus 1 (HSV-1) replicates in epithelial cells and then spreads to the trigeminal ganglia (TG) via nerve termini, where it replicates but then ultimately establishes latency in neurons (1). In humans, reactivation of HSV-1 can lead to recurrent lesions on labial
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.